Pradaxa Reversal Agent Approved

November 3, 2015

In 2010, the FDA approved the prescription blood-thinning drug Pradaxa (dabigatran) to prevent stroke and systemic blood clots in patients with atrial fibrillation, as well as for the treatment and prevention of deep venous thrombosis and pulmonary embolism. On October 16, 2015, the FDA granted acc[...]

Continue Reading

CDC’s Shocking New Autism Data

March 28, 2014

On March 27, 2014, the CDC released new data regarding autism spectrum disorder (ASD) in the United States based on a review of records of 8-year-olds (more than 5,300) in certain areas of Alabama, Arizona, Arkansas, Colorado, Georgia, Maryland, Missouri, New Jersey, North Carolina, Utah, and Wis[...]

Continue Reading

New Study Finds New Doctors Are Discourteous

October 29, 2013

The results of an observational study conducted by Johns Hopkins investigators regarding new doctors (first year interns at The Johns Hopkins Hospital and at the University of Maryland Medical Center in Baltimore) that was published this month online in the Journal of Hospital Medicine found that t[...]

Continue Reading

Study Finds Premarin Linked To Higher Risk Of Clots

October 2, 2013

A study published on September 30, 2013 in JAMA Internal Medicine found that women who were taking Premarin (conjugated equine estrogen) for menopause had double the risk (odds ratio, 2.08) of developing venous thrombosis (clots in the veins) than woman who took estradiol, both of which are oral es[...]

Continue Reading

1 2 3 4 5 6